Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Businesswire News Releases

May 24, 2024 07:00 ET
GoldATM’s Momentum and Growth Continues with Launch of Online Store
Thanks to the growing interest and awareness in gold, GoldATM, the ATM industry’s emerging leader and first provider of true Gold ATMs, is advancing even faster with the addition of the company's new online e-commerce store, branded as Autm....
May 24, 2024 07:00 ET
hC Bioscience Announces Program in Duchenne Muscular Dystrophy and Reports In Vivo Data From tRNA-based Protein Editing Platform
hC Bioscience, a biopharmaceutical company developing a fundamentally novel approach to treating genetic diseases through tRNA-based protein editing, today announced preclinical data supporting its program in Duchenne muscular dystrophy (DMD) at the CureDuchenne FUTURES National Conference in Orlando, Fla....
May 24, 2024 07:00 ET
Magellan Aerospace Announces Renewal of Normal Course Issuer Bid
Magellan Aerospace Corporation (“Magellan or Corporation") (TSX: MAL) announced today that the Toronto Stock Exchange has accepted notice filed by Magellan to make a normal course issuer bid (“NCIB”) through facilities of the Toronto Stock Exchange (the “TSX”) or other alternative Canadian trading systems....
May 24, 2024 07:00 ET
Pro-Vac Completes Acquisition of Kinetic
Pro-Vac, a leading provider of essential subsurface infrastructure services, announced today that it has acquired Kinetic, a leading provider of hydro excavation services in the Rocky Mountain region and DMV-area. The combination significantly enhances and expands Pro-Vac’s scale and geographic reach. The combination was supported by Gallant Capital Partners (“Gallant”), the majority owner of Pro-Vac....
May 24, 2024 07:00 ET
Verastem Oncology Announces the Initiation of a Rolling Submission of NDA to FDA Seeking Accelerated Approval of Avutometinib and Defactinib Combination for the Treatment of Adult Patients with Recurr
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it has initiated the rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking accelerated approval of the combination of avutometinib, a RAF/MEK clamp, and defactinib, a selective FAK inhibitor, for adult patients with recurrent KRAS mutant (KRAS mt) low-grade serous ovarian cancer (LGSOC), who received at least one prior systemic therapy. The rolling review process allows the Company to submit complet...
May 24, 2024 06:50 ET
Kenvue Announces Participation in Deutsche Bank's dbAccess Global Consumer Conference
Kenvue Inc. (NYSE: KVUE) (“Kenvue”) today announced the Company’s participation in Deutsche Bank’s dbAccess Global Consumer Conference in Paris, France. Thibaut Mongon, Chief Executive Officer, Paul Ruh, Chief Financial Officer, and Carlton Lawson, Group President, Europe, Middle East and Africa & Latin America will participate in a fireside chat on Tuesday, June 4, 2024, at 8:45 a.m. Eastern Time / 2:45 p.m. Central European Time. A live webcast of the session will be available on
May 24, 2024 06:50 ET
The Buckle, Inc. Reports First Quarter Net Income
The Buckle, Inc. (NYSE: BKE) announced today that net income for the fiscal quarter ended May 4, 2024 was $34.8 million, or $0.70 per share ($0.69 per share on a diluted basis)....
May 24, 2024 06:45 ET
Booz Allen Hamilton Announces Fourth Quarter and Full Fiscal Year 2024 Results
Booz Allen Hamilton Holding Corporation (NYSE: BAH), the parent company of management and technology consulting and engineering services firm Booz Allen Hamilton Inc., today announced preliminary results for the fourth quarter and full fiscal year 2024....
May 24, 2024 06:30 ET
KalVista Pharmaceuticals Announces Ten Abstracts Accepted for Presentation at the European Academy of Allergy and Clinical Immunology Congress 2024
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced the acceptance of multiple abstracts and a symposium at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2024 taking place in Valencia, Spain from May 31-June 3....
May 24, 2024 06:05 ET
Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, will present 10 abstracts highlighting the breadth and depth of the company’s screening and diagnostic portfolio at the American Society of Clinical Oncology® (ASCO®) Annual Meeting, taking place May 31 – June 4, 2024, in Chicago, Ill. Presentations will include new data confirming both the predictive and prognostic value of the Oncotype DX Breast Recurrence Score® test in racially and ethnically diverse patients. Exact Sciences will also present data on its approa...
May 24, 2024 06:05 ET
TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants
TriSalus Life Sciences® Inc. (“TriSalus” or the “Company”) (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, announced today that it has commenced an exchange offer (the “Offer”) and consent solicitation (the...
May 24, 2024 06:00 ET
BRUKINSA® Data at ASCO Underscore Differentiated Clinical Profile for Treatment of CLL and SLL
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced the presentation of new analyses for BRUKINSA® (zanubrutinib) at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31 - June 4, 2024. The presentations highlight analyses of the efficacy and safety of BRUKINSA compared to other Bruton’s tyrosine kinase inhibitors (BTKis) used to treat chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL)....
May 24, 2024 06:00 ET
European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14
Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) today announced that the European Medicines Agency (EMA) has validated the marketing authorization applications (MAAs) for HLX14, an investigational Prolia® and Xgeva® (denosumab) biosimilar. Denosumab has been approved in various countries and regions under different trade names for a range of different indications such as for the treatment of osteoporosis in postmenopausal women at high risk for fracture, among others. In 2019, it was estimated that 32 million Europeans ages 50 or above had osteoporosis, 2...
May 24, 2024 06:00 ET
National Grid Recognizes Runwise - Top ProNet Partner in 2023 For Energy Conservation
Runwise was celebrated for outstanding achievements in energy efficiency by
May 24, 2024 06:00 ET
The Duckhorn Portfolio Announces Enhanced Distribution Relationships with Republic National Distributing Company and Breakthru Beverage Group
The Duckhorn Portfolio, Inc. (NYSE: NAPA) (the “Company”) announced today that it has entered into distribution agreements with Republic National Distributing Company (RNDC) and Breakthru Beverage Group (BBG). The Company’s entry into these agreements is the culmination of a comprehensive strategic evaluation of its wholesale distribution network across the United States, with the goal of driving the profitable growth of the Company’s sales through a substantial increase in focus and investment in the wholesale channel. It is expected that RNDC and BBG will begin distribution of Duckhorn’s win...
May 24, 2024 06:00 ET
Vertical Aerospace Releases First Quarter 2024 Financial Results
Vertical Aerospace Ltd. (“Vertical” or the “Company”) (NYSE: EVTL; EVTLW), a global aerospace and technology company that is pioneering zero emission aviation, today announces its financial results for the first quarter ended March 31, 2024. The first quarter 2024 financial results filing can be found on the
May 24, 2024 05:00 ET
Nidec Announces Material Weakness About Nidec’s Internal Control Over Its Financial Reporting
Nidec Corporation (TOKYO: 6594; OTC US: NJDCY) (the “Company”) announces today that it has identified a material weakness in its internal control report for the fiscal year ended March 31, 2023 audited by our auditor that the Company submitted to the Kanto Local Finance Bureau in accordance with Article 24-4-4(1) of the Financial Instruments and Exchange Act. Accordingly, pursuant to Article 24-4-5(1) of the Act, the Company stated, in the amendment report for its internal control report for the same fiscal term that it submitted to the Kanto Local Finance Bureau, that the Company’s internal c...
May 24, 2024 05:00 ET
Notice regarding the Partial Amendments of Previous Financial Statements Summary, Securities Reports and Internal Control Report
Nidec Corporation (TOKYO: 6594; OTC US: NJDCY) (the “Company”) today submitted amendment reports to its Securities Reports, Quarterly Reports and Internal Control Report audited by our auditor and submitted in previous fiscal years, to Kanto Local Finance Bureau. The Company also partially amended previous financial statements summary and disclose the documents. We sincerely apologize for the considerable inconvenience caused to our shareholders, investors, business partners, and all the stakeholders....
May 24, 2024 03:05 ET
E3 Lithium Files First Quarter 2024 Financial Statements and MD&A
E3 LITHIUM LTD. (TSXV: ETL) (FSE: OW3) (OTCQX: EEMMF), “E3 Lithium” or the “Company,” a leader in Canadian lithium, today filed its Unaudited Condensed Consolidated Interim Financial Statements for the first quarter of 2024 and the accompanying Management’s Discussion and Analysis (“MD&A) on its SEDAR+ profile at www.sedarplus.ca. The financial statemen...